出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/10/17 08:53:54」(JST)

wiki en

[Wiki en表示]

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2017/10/26 11:02:13」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Double pituitary adenomas.
  • Iacovazzo D, Bianchi A, Lugli F, Milardi D, Giampietro A, Lucci-Cordisco E, Doglietto F, Lauriola L, De Marinis L.SourceDepartment of Endocrinology, Catholic University, Policlinico "A. Gemelli", Largo A. Gemelli, 8, 00168, Rome, Italy,
  • Endocrine.Endocrine.2013 Apr;43(2):452-7. doi: 10.1007/s12020-013-9876-3. Epub 2013 Jan 17.
  • Double pituitary adenomas represent up to 2.6 % of pituitary adenomas in large surgical series and up to 3.3 % of patients with Cushing's disease have been found to have double or multiple pituitary adenomas. We report the case of a 60-year-old male patient whose medical history began in 2002 with
  • PMID 23325364
  • Dopamine d2 receptor modulation of human response inhibition and error awareness.
  • Nandam LS, Hester R, Wagner J, Dean AJ, Messer C, Honeysett A, Nathan PJ, Bellgrove MA.SourceThe University of Queensland.
  • Journal of cognitive neuroscience.J Cogn Neurosci.2013 Apr;25(4):649-56. doi: 10.1162/jocn_a_00327. Epub 2012 Nov 19.
  • Response inhibition, comprising action cancellation and action restraint, and error awareness are executive functions of considerable clinical relevance to neuropsychiatric disorders. Nevertheless, our understanding of their underlying catecholamine mechanisms, particularly regarding dopamine, is li
  • PMID 23163418
  • Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.
  • Ciresi A, Amato MC, Guarnotta V, Lo Castro F, Giordano C.SourceSection of Endocrinology, Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.Mi.S), University of Palermo, Italy.
  • Clinical endocrinology.Clin Endocrinol (Oxf).2013 Mar 18. doi: 10.1111/cen.12204. [Epub ahead of print]
  • OBJECTIVE: Currently available studies that fully analyze the metabolic parameters in patients with prolactinoma are scarce and discordant. The aim of this study was to evaluate the metabolic effects of cabergoline (CAB) treatment in patients with newly diagnosed prolactinoma in relation to disease
  • PMID 23506485


  • Medical Management of Functioning Pituitary Adenoma: An Update
  • OKI Yutaka
  • Neurologia medico-chirurgica, 2014
  • … In patients with prolactinoma, dopamine agonists, especially cabergoline, are quite efficient. …
  • NAID 130004922291
  • Medical Management of Functioning Pituitary Adenoma: An Update
  • OKI Yutaka
  • Neurologia medico-chirurgica 54(12), 958-965, 2014
  • … In patients with prolactinoma, dopamine agonists, especially cabergoline, are quite efficient. …
  • NAID 130004704540
  • Bromocriptine, a Dopamine Agonist, Increases Growth Hormone Secretion in a Patient with Acromegaly
  • Arihara Zenei,Sakurai Kanako,Yamashita Rika,Niitsuma Satsuki,Ueno Takayuki,Yamamura Nao,Yamada Shozo,Inoshita Naoko,Takahashi Kazuhiro
  • The Tohoku Journal of Experimental Medicine 234(2), 129-135, 2014
  • Bromocriptine, a potent D2-dopamine agonist, suppresses growth hormone (GH) secretion in most patients with acromegaly and has been approved for the treatment of acromegaly. Here we report a patient …
  • NAID 130004691038


Before taking cabergoline, tell your doctor and pharmacist if you are allergic to cabergoline, ergot medications such as bromocriptine (Parlodel); dihydroergotamine (D.H.E. 45, Migranal), ergoloid mesylates (Hydergine ...
Easy to read patient leaflet for cabergoline. Includes indications, proper use, special instructions, precautions, and possible side effects. ... If OVERDOSE is suspected: Contact 1-800-222-1222 (the American Association of Poison ...